Streetbeat News

Products Services

BNTX

The FDA has lifted the partial clinical hold on MediLink Therapeutics' Phase 1 trial for the cancer drug BNT326/YL202, partnered with BioNTech. The trial will resume with a lower dose to ensure safety, following concerns about adverse effects at higher doses.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:39 pm

XPEV

XPeng Inc (NYSE:XPEV) is facing bearish signals ahead of its Mona M03 launch on Aug. 27, following its Q2 earnings report on Aug. 20. The stock is down over 50% YTD and is trading below key moving averages, indicating a downward trend. Analysts see a potential 26.23% upside with a price target of $9.

Portfolio Pulse from Surbhi Jain

August 19, 2024 | 1:36 pm

KSCP

Knightscope has secured two new contracts for its emergency communication devices. An Episcopal school in Southern California is expanding with an additional K1 Blue Light Tower, and Ohio healthcare clinics are upgrading existing towers with K1 Retrofit Kits.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:35 pm

TLS

Telos Corporation, an official TSA PreCheck enrollment provider, has expanded its services to eight new locations across the U.S., increasing its total to 91 centers. This expansion is part of Telos' ongoing efforts to enhance convenience for consumers by offering more enrollment centers and extended hours.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:30 pm

GSAT

Globalstar has secured a 15-year license extension from the FCC to operate up to 26 replacement satellites, ensuring continued exclusive operations in the Big LEO band.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:28 pm

WDS

Woodside Energy Group Ltd (NYSE:WDS) shares rise after reaching an agreement to dismiss a legal challenge against its Scarborough Energy Project. The project, which is 67% complete, has secured all primary environmental approvals. Woodside also announced a $2.35 billion acquisition of OCI Global's Clean Ammonia project.

Portfolio Pulse from Lekha Gupta

August 19, 2024 | 1:26 pm

HIMS

LLY

NVO

Hims & Hers Health Inc (NYSE:HIMS) has seen its stock soar over 120% since August 2023 due to high demand for compounded weight-loss drugs amid supply shortages. This surge surpasses gains by Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO). Hims capitalized on the scarcity of GLP-1 drugs by offering affordable alternatives, but faces legal challenges and potential stock vulnerability once shortages resolve.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:24 pm

FNGR

FingerMotion's C2 Platform, developed by JiuGe Technology, has received national certification from China's MIIT, enabling expedited distribution of emergency response vehicles across China.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:20 pm

NFE

New Fortress Energy Inc. (NASDAQ:NFE) has announced the completion of scheduled maintenance for its Fast LNG 1 asset in Altamira, Mexico. The asset has resumed production and is expected to reach full capacity later this month.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:19 pm

MULN

Mullen Automotive has sold its Mullen THREE, a Class 3 EV box truck, to Princeton University's facilities operations to support campus operations and sustainability goals. This sale aligns with Princeton's efforts to achieve net-zero carbon emissions by 2046.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:18 pm